Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county‐level income in the United States, 2000–2019
Top Cited Papers
- 25 January 2024
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 154 (9) , 1549-1555
Abstract
Early evidence suggests that declining cervical cancer incidence reversed in low‐income regions in the United States in recent years; however, it is unclear whether there are distinct patterns by race/ethnicity and stage at diagnosis and if the increase has translated into rising mortality. Using Surveillance, Epidemiology, and End Results data, we evaluated trends in hysterectomy‐corrected cervical cancer incidence rates (2000–2019) and mortality rates (2005–2019) by county‐level income and race/ethnicity, with further stratification of incidence by stage at diagnosis. Following a period of decline, hysterectomy‐corrected cervical cancer incidence increased 1.0%/year (95% CI = 0.1% to 4.5%) among Non‐Hispanic White women in low‐income counties. Particularly, a statistically significant 4.4%/year (95% CI = 1.7% to 7.5%) increase in distant‐stage cancer occurred in this group. Additionally, recent increases in cervical cancer mortality (1.1%/year [95% CI = −1.4% to 3.7%]) were observed among this group and Non‐Hispanic Black women in low‐income counties (2.9%/year [95% CI = −2.3% to 18.2%]), but trends were not statistically significant. Among Hispanic women in low‐income counties, distant‐stage cervical cancer incidence increased 1.5%/year (95% CI = −0.6% to 4.1%), albeit not statistically significant. The increasing incidence of distant‐stage cervical cancer and mortality in specific racial/ethnic groups suggests that the recent introduction of higher sensitivity screening tests may not explain increasing trends in low‐income counties. Our findings suggest that the observed rise in cervical cancer incidence may reflect disruptions along the screening and treatment continuum. Future research to further comprehend these trends and continued enhancements in prevention are crucial to combat rising cervical cancer incidence and mortality in low‐income counties in the United States.Keywords
Funding Information
- National Cancer Institute (R01CA232888)
- National Institute on Minority Health and Health Disparities (3R01MD013715‐04S1, K01MD016440, R01MD013715)
This publication has 12 references indexed in Scilit:
- Cancer Screening Test Use―U.S., 2019American Journal of Preventive Medicine, 2022
- Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017JAMA Network Open, 2022
- Trends in the Incidence of Human Papillomavirus-Associated Cancers by County-Level Income and Smoking Prevalence in the United States, 2000-2018JNCI Cancer Spectrum, 2022
- Assessment of US Preventive Services Task Force Guideline–Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019JAMA Network Open, 2022
- High-Grade Vulvar, Vaginal, and Anal Precancers Among U.S. Adolescents and Young Adults After Human Papillomavirus Vaccine IntroductionAmerican Journal of Preventive Medicine, 2022
- The IARC Perspective on Cervical Cancer ScreeningNew England Journal of Medicine, 2021
- Evaluation of Cervical Cancer Screening Uptake and Adherence Among Women Without Human Papillomavirus Vaccination in the USJAMA Network Open, 2021
- Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017JNCI: Journal of the National Cancer Institute, 2020
- Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003–2014Preventive Medicine Reports, 2018
- Why does cervical cancer occur in a state-of-the-art screening program?Gynecologic Oncology, 2017